Safe Handling, PPE, Occupational Health, and Exposure Response
Key Takeaways
- Hazardous drug precautions protect nurses, patients, caregivers, and the environment across receipt, storage, preparation, administration, disposal, and spill response.
- USP General Chapter <800> and the NIOSH 2024 Hazardous Drug List drive policy; antineoplastic administration requires two pairs of chemotherapy-tested gloves and a tested gown.
- Exposure response requires immediate decontamination first, then prompt reporting, occupational health evaluation, and documentation.
- Engineering controls and work-practice controls sit above PPE in the hierarchy of controls; PPE alone cannot fix unsafe workflow.
Safe Handling, PPE, Occupational Health, and Exposure Response
Hazardous drug risk in oncology
Many antineoplastic and related agents are hazardous drugs (HDs) because they may be carcinogenic, genotoxic, teratogenic, toxic to reproduction, or organ-toxic at low doses. Exposure occurs through skin contact, inhalation, ingestion, accidental injection, contaminated surfaces, spills, priming tubing, disconnecting lines, crushing tablets, handling contaminated body fluids (treat excreta as contaminated for 48 hours after most regimens per policy), and waste disposal.
OCN candidates must think well beyond the moment of infusion: safe handling begins when the drug enters the organization and continues through storage, compounding, transport, administration, disposal, cleaning, and post-administration patient care.
USP General Chapter <800>, the NIOSH 2024 List of Hazardous Drugs in Healthcare Settings (which replaced the 2016 list in December 2024), OSHA standards, and organizational policy support a hierarchy of controls that reduces exposure before relying on individual behavior.
| Control level | Examples (most to least protective) |
|---|---|
| Engineering | Biological safety cabinets, containment isolators, closed-system drug-transfer devices (CSTDs), negative-pressure compounding rooms, sharps-safety devices. |
| Work practice | No eating/drinking in handling areas, no clipping contaminated tubing, safe priming, luer-lock connections, HD labeling, avoiding aerosols. |
| PPE | Two pairs of chemotherapy gloves, tested impervious gown, eye/face and respiratory protection by task. |
PPE for oncology tasks
PPE must match the task and policy. For administering antineoplastic HDs, USP <800> expects two pairs of chemotherapy-tested (ASTM D6978) gloves and a disposable, lint-free, low-permeability gown with a closed front and tight cuffs. Eye and face protection are added when splashing is possible; respiratory protection (a fit-tested N95 or higher) is required for spill, aerosol, or powder risk. Replace gloves about every 30 minutes or immediately when torn or contaminated, and gowns about every 2 to 3 hours or when soiled.
| Task | Typical protection focus |
|---|---|
| IV antineoplastic administration | Two pairs chemotherapy gloves, tested gown, closed connections, safe disposal in yellow HD waste. |
| Oral hazardous drug handling | Avoid bare-hand contact, glove up; do not crush or split unless pharmacy/policy explicitly allow. |
| Body fluid handling after therapy | Gloves and gown when contact is likely; follow facility time frames and waste rules. |
| Spill response | Trained staff only, spill kit, PPE per policy, area control, cleanup, reporting. |
Patients and caregivers also need practical education: handling oral HDs, storing them away from children and pets, not loading tablets into pill organizers without guidance, returning unused drug properly, gloving for contaminated linens or excreta when advised, and whom to call after accidental exposure. Document this teaching.
Bloodborne pathogens and infection exposure
Oncology nurses also face bloodborne pathogen risk from central-line access, phlebotomy, injections, drains, wounds, and sharps. Standard precautions apply to every patient because infection status may be unknown. The OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) requires an exposure control plan, safer-engineered devices, training, PPE, an offered hepatitis B vaccination, post-exposure evaluation, and recordkeeping.
In practice: use safety needles, activate sharps protection immediately, never recap by hand unless an approved exception applies, dispose of sharps at the point of use, and wear PPE whenever blood or body-fluid exposure is reasonably anticipated.
Exposure and spill response
For any HD splash, needlestick, or mucous-membrane exposure, decontaminate first, then report. For skin exposure, remove contaminated PPE/clothing and wash with soap and water. For eye exposure, flush at an eyewash station for the time specified by policy (commonly at least 15 minutes). For a needlestick, wash the site, report promptly, and follow occupational-health evaluation. Do not wait until shift end; early reporting enables medical evaluation, source assessment, post-exposure prophylaxis decisions, documentation, and process improvement.
Spill response follows the facility spill plan. Priorities in order: protect people, restrict the area, retrieve the spill kit, don required PPE, clean per kit instructions, dispose of waste as HD waste, and report. Untrained staff must not improvise cleanup. A large spill, powder aerosolization, broken glass, or eye/skin contact may require pharmacy, environmental services, employee health, or safety-officer support.
Safety culture
Safe handling is sustained by training, competency validation, audits, clear labeling, accessible spill kits, adequate staffing, and leadership support. Nurses should report missing PPE, unsafe workflow, contaminated surfaces, leaking connections, and unclear policies. For the exam, remember worker safety and patient safety are linked: a nurse who shortcuts PPE, skips a double check, or hides an exposure weakens the whole safety system.
Extravasation: a handling emergency
Extravasation (leakage of a vesicant into surrounding tissue) is the classic oncology handling emergency and a frequent exam topic. At the first sign of swelling, burning, redness, leaking, loss of blood return, or resistance, stop the infusion immediately, leave the catheter in place, and aspirate residual drug before removing it. Notify the provider, follow the antidote and thermal protocol, and document the site, estimated volume, symptoms, and interventions with photographs when policy allows.
Thermal management is agent-specific: cold compresses for most vesicants such as doxorubicin, but warm compresses and hyaluronidase for vinca alkaloids. Applying the wrong temperature can worsen injury, which is a common distractor.
Waste segregation and environmental health
Hazardous-drug waste is not regular trash. Trace-contaminated items (empty bags, tubing, PPE) go in yellow HD waste, while bulk or RCRA-listed agents may require black hazardous-waste containers. Sharps go to point-of-use sharps containers. Mixing HD waste with regular or red biohazard waste is a compliance failure that surveyors flag. Environmental health, a Standard of Professional Performance, also covers safe storage temperatures, segregated HD receiving and storage areas, and deactivation/decontamination of work surfaces with appropriate agents.
Reproductive and vulnerable-worker protections
USP <800> recognizes that some HDs are reproductive toxins. Policies should allow staff who are pregnant, trying to conceive, or breastfeeding to review the NIOSH list and request alternative duty without penalty. The exam may present a pregnant nurse asked to administer a known teratogen; the correct response respects the organization's reproductive-safety policy rather than dismissing the risk or refusing all assignments outright.
During IV antineoplastic administration, a nurse notices that the outer chemotherapy glove is torn. What is the priority action?
A small amount of hazardous drug splashes into a nurse's eye. What should the nurse do first?
Which statement by a nurse handling oral hazardous medication indicates correct practice?